Table of Contents
Vitamins and Dietary Supplements in France
Euromonitor International
April 2009
List of Contents and Tables
Executive Summary
OTC
Healthcare Suffers From Consumers Obtaining More Prescription Products
Increasing Presence of Self-service Areas in Chemists/pharmacies for OTC
Products
A Fragmented Market Led by OTC Manufacturers
Chemists/pharmacies Remains the Leading Distribution Channel
Positive
Performance Through the Development of Self-medication
Key Trends and
Developments
the Setting-up of Self-service: Its Impact on
Self-medication
Vitamins and Dietary Supplements for Everyone
the Grey
Market Is the New Key Target Consumer Group
Decreasing Purchasing Power
Favours Rx Products
Market Indicators
Table 1 Consumer Expenditure on
Health Goods and Medical Services 2003-2008
Table 2 Life Expectancy at
Birth 2003-2008
Market Data
Table 3 Sales of OTC Healthcare by Sector:
Value 2003-2008
Table 4 Sales of OTC Healthcare by Sector: % Value Growth
2003-2008
Table 5 OTC Healthcare Company Shares by Value 2004-2008
Table 6 OTC Healthcare Brand Shares by Value 2005-2008
Table 7 Penetration
of Private Label by Sector 2003-2008
Table 8 Sales of OTC Healthcare by
Distribution Format: % Analysis 2003-2008
Table 9 Sales of OTC Healthcare
by Sector and Distribution Format: % Analysis 2008
Table 10 Forecast Sales
of OTC Healthcare by Sector: Value 2008-2013
Table 11 Forecast Sales of
OTC Healthcare by Sector: % Value Growth 2008-2013
Appendix
OTC
Registration and Classification
Advertising
Packaging and
Labelling
Distribution
Vitamins & Dietary Supplements Registration and
Classification
EU Legislation
Self-medication and Preventative
Medicine
Generics
Switches
Summary 1 Rx-to-OTC Healthcare Switches
2006-2008
Definitions
Summary 2 Research Sources
Arkopharma Sa,
Laboratoires Pharmaceutiques
Strategic Direction
Key Facts
Summary
3 Laboratoires Pharmaceutiques Arkopharma SA: Key Facts
Summary 4
Laboratoires Pharmaceutiques Arkopharma SA: Operational Indicators
Company
Background
Competitive Positioning
Summary 5 Laboratoires
Pharmaceutiques Arkopharma SA: Competitive Position 2008
Beaufour-ipsen
SA
Strategic Direction
Key Facts
Summary 6 Beaufour-Ipsen SA: Key
Facts
Summary 7 Beaufour-Ipsen SA: Operational Indicators
Company
Background
Production
Summary 8 Beaufour-Ipsen SA: Production
Statistics 2007
Competitive Positioning
Summary 9 Beaufour-Ipsen SA:
Competitive Position 2008
Cooper SA
Strategic Direction
Key
Facts
Summary 10 Cooper SA: Key Facts
Summary 11 Cooper SA:
Operational Indicators
Company Background
Production
Summary 12
Cooper SA: Production Statistics 2007
Competitive Positioning
Summary
13 Cooper SA: Competitive Position 2008
GlaxoSmithKline Santé Grand Public
Sas
Strategic Direction
Key Facts
Summary 14 GlaxoSmithKline Santé
Grand Public SAS: Key Facts
Summary 15 GlaxoSmithKline Santé Grand Public
SAS: Operational Indicators
Company Background
Production
Summary
16 GlaxoSmithKline France: Production Statistics 2007
Competitive
Positioning
Summary 17 GlaxoSmithKline Santé Grand Public SAS: Competitive
Position 2008
Juva Santé Laboratoires
Strategic Direction
Key
Facts
Summary 18 Laboratoires Juva Santé Key Facts
Summary 19
Laboratoires Juva Santé Operational Indicators
Company Background
Production
Summary 20 Laboratoires Juva Santé Production Statistics
2006
Competitive Positioning
Summary 21 Laboratoires Juva Santé
Competitive Position 2008
Laboratoires Mcneil
Strategic Direction
Key Facts
Summary 22 Laboratoires McNeil: Key Facts
Summary 23
Laboratoires McNeil: Operational Indicators
Company Background
Competitive Positioning
Summary 24 Laboratoires McNeil: Competitive
Position 2008
Pierre Fabre Sa, Laboratoires
Strategic Direction
Key Facts
Summary 25 Laboratoires Pierre Fabre SA: Key Facts
Summary
26 Laboratoires Pierre Fabre SA: Operational Indicators
Company
Background
Production
Summary 27 Laboratoires Pierre Fabre SA:
Production Statistics 2007
Competitive Positioning
Summary 28
Laboratoires Pierre Fabre SA: Competitive Position 2008
Théraplix SA
Strategic Direction
Key Facts
Summary 29 Théraplix SA: Key Facts
Company Background
Competitive Positioning
Summary 30 Théraplix SA:
Competitive Position 2008
Upsa, Laboratoires
Strategic Direction
Key Facts
Summary 31 Laboratoires UPSA: Key Facts
Summary 32
Laboratoires UPSA: Operational Indicators
Company Background
Production
Summary 33 UPSA Conseil SAS: Production Statistics 2007
Competitive Positioning
Summary 34 UPSA Conseil SAS: Competitive Position
2008
Urgo, Laboratoires
Strategic Direction
Key Facts
Summary
35 Laboratoires Urgo: Key Facts
Summary 36 Laboratoires Urgo: Operational
Indicators
Company Background
Production
Competitive
Positioning
Summary 37 Laboratoires Urgo: Competitive Position 2008
Headlines
Trends - Vitamins
Trends - Dietary Supplements
Competitive Landscape
Prospects
Sector Data
Summary 38 Dietary
Supplements: Brand Ranking by Positioning 2008
Table 12 Sales of Vitamins
and Dietary Supplements by Subsector: Value 2003-2008
Table 13 Sales of
Vitamins and Dietary Supplements by Subsector: % Value Growth 2003-2008
Table 14 Folic Acid v Other B Vitamins 2004-2008
Table 15 Dietary
Supplements by Positioning 2006-2008
Table 16 Vitamins and Dietary
Supplements Company Shares by Value 2004-2008
Table 17 Vitamins and
Dietary Supplements Brand Shares by Value 2005-2008
Table 18 Vitamins
Brand Shares by Value 2005-2008
Table 19 Dietary Supplements Brand Shares
by Value 2005-2008
Table 20 Forecast Sales of Vitamins and Dietary
Supplements by Subsector: Value 2008-2013
Table 21 Forecast Sales of
Vitamins and Dietary Supplements by Subsector: % Value Growth 2008-2013
| 
View Cart
